When Danish pharmaceutical giant Novo Nordisk introduced Ozempic, it was more than just a breakthroughâit was a testament to their motto: “Driving Change Across Generations.”
This injectable has transformed the lives of millions battling uncontrolled diabetes, delivering unprecedented effectiveness.
The secret? It not only controls blood sugar but also drives weight loss, tackling two interconnected challengesâdiabetes and obesityâthat fuel each other in a vicious cycle.
But in Indiaâthe diabetes capital of the worldâpatients prefer pills over injectables. Novo Nordisk understood this and took innovation a step further.